Literature DB >> 29589197

Spontaneous bacteremia and spontaneous bacterial peritonitis in cirrhosis: two infections but similar outcomes?

Rakhi Maiwall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29589197     DOI： 10.1007/s12072-018-9853-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  11 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  Management of bacterial infections in cirrhosis.

Authors:  Javier Fernández; Thierry Gustot
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

3.  Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.

Authors:  Mónica Guevara; Carlos Terra; André Nazar; Elsa Solà; Javier Fernández; Marco Pavesi; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-06-23       Impact factor: 25.083

4.  Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.

Authors:  Lidia Dalfino; Filomena Puntillo; Maria Josephine Mura Ondok; Adriana Mosca; Rosa Monno; Sara Coppolecchia; Maria Luigia Spada; Francesco Bruno; Nicola Brienza
Journal:  Clin Infect Dis       Date:  2015-09-09       Impact factor: 9.079

5.  Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.

Authors:  Javier Fernández; Juan Acevedo; Verónica Prado; Mario Mercado; Miriam Castro; Marco Pavesi; Mireya Arteaga; Lydia Sastre; Adria Juanola; Pere Ginès; Vicente Arroyo
Journal:  Liver Int       Date:  2016-09-20       Impact factor: 5.828

6.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

7.  Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.

Authors:  Thierry Thévenot; Christophe Bureau; Frédéric Oberti; Rodolphe Anty; Alexandre Louvet; Aurélie Plessier; Marika Rudler; Alexandra Heurgué-Berlot; Isabelle Rosa; Nathalie Talbodec; Thong Dao; Violaine Ozenne; Nicolas Carbonell; Xavier Causse; Odile Goria; Anne Minello; Victor De Ledinghen; Roland Amathieu; Hélène Barraud; Eric Nguyen-Khac; Claire Becker; Thierry Paupard; Danielle Botta-Fridlung; Naceur Abdelli; François Guillemot; Elisabeth Monnet; Vincent Di Martino
Journal:  J Hepatol       Date:  2014-11-21       Impact factor: 25.083

8.  Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.

Authors:  Alexandra Alexopoulou; Nikolaos Papadopoulos; Dimitrios G Eliopoulos; Apostolia Alexaki; Athanasia Tsiriga; Marina Toutouza; Dimitrios Pectasides
Journal:  Liver Int       Date:  2013-03-24       Impact factor: 5.828

9.  Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.

Authors:  Dominique Thabut; Julien Massard; Alice Gangloff; Nicolas Carbonell; Claire Francoz; Eric Nguyen-Khac; Christian Duhamel; Didier Lebrec; Thierry Poynard; Richard Moreau
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  Spontaneous bacteremia and spontaneous bacterial peritonitis share similar prognosis in patients with cirrhosis: a cohort study.

Authors:  Sebastián Marciano; Melisa Dirchwolf; Carla S Bermudez; Natalia Sobenko; Leila Haddad; Federico Genre Bert; Laura Barcán; Astrid Smud; Maria Lourdes Posadas-Martínez; Diego Giunta; Adrián Gadano
Journal:  Hepatol Int       Date:  2017-12-09       Impact factor: 6.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.